2m 2m 2m 2m 2m 2m 2m
UNICYCIVE THERAP (UNCY)
NASDAQ
$7.16-$0.04 (-0.57%)
Price as of Jun 03, 2026 7:55 PM EDT- $197.0MMarket Cap
- -7.10%1-Year Change
- BiotechnologyIndustry
UNICYCIVE THERAP (UNCY)
$7.16-$0.04 (-0.57%)
UNCY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.20 | ||
Change | -$0.03 (-0.41%) | ||
Open | $7.31 | ||
High | $7.41 | ||
Low | $7.10 | ||
Previous Close | $7.23 | ||
Volume | 513,828 | ||
30-Day Average Volume | 714,118 | ||
1-Week Change | 1.84% | ||
1-Month Change | -6.13% | ||
1-Year Change | -7.10% | ||
3-Year Change | -48.20% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 26.7M | ||
Total Assets | $64.4M | ||
Market Cap | $197.0M | ||
Enterprise Value | $159.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$12.8M | ||
Free Cash Flow | -$6.2M | ||
EBIT | -$12.8M | ||
EBITDA | -$12.8M | ||
Net Working Capital | $37.1M | ||
EPS | -$0.54 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -14 | ||
PEG | 0 | ||
Price/Free Cash Flow | -32 | ||
Price/Operating Cash Flow | -32 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/20/2025 | ||
Earnings & Revenue